SCHEMBL6552186

SCHEMBL6552186

NC(=O)N(c1ccc(F)cc1F)c1ccc(F)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
ALDH1A1 P00352 2/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
PRKD3 O94806 1/20 0.41
MAPK9 P45984 1/20 0.41
MAPKAPK2 P49137 1/20 0.41
MAPK10 P53779 1/20 0.41
ROCK1 Q13464 1/20 0.41
ACVR2B Q13705 1/20 0.41
MYLK Q15746 1/20 0.41
MAPK11 Q15759 1/20 0.41
MAPK14 Q16539 1/20 0.41
PRKD2 Q9BZL6 1/20 0.41
NLK Q9UBE8 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
ALK Q9UM73 1/20 0.41
KCNN4 O15554 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28252495 0.84 ALDH1A1 (0.36) CES2CES1ALDH1A1TSHRMAPK1
SCHEMBL6037479 0.84 KDR (0.42) CES2CES1ALDH1A1TSHRMAPK1
SCHEMBL17938246 0.81 PKM (0.40) CES2CES1ALDH1A1PRKD3MAPK9
SCHEMBL6258541 0.77 SCN8A (0.40)
SCHEMBL14717233 0.77 CA2 (0.50)
SCHEMBL30883191 0.75 L3MBTL1 (0.43) CES2CES1ALDH1A1PRKD3PRKD2
SCHEMBL2093494 0.74 NPSR1 (0.48) CES2CES1ALDH1A1TSHRMAPK1
SCHEMBL11218595 0.73 PARP1 (0.41) CES2CES1PRKD3MAPK9MAPKAPK2
SCHEMBL2093491 0.73 NPSR1 (0.47) CES2CES1ALDH1A1TSHRMAPK1
SCHEMBL28023898 0.72 PARP1 (0.38) CES2CES1ALDH1A1KCNN4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1149063-B1 UREIDO-THIOBUTYRIC ACID DERIVATIVES AS PPAR-AGONISTS SMITHKLINE BEECHAM CORP (US) 2004-12-15 EP disclosed
EP-1244642-B1 SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS HPPAR ALPHA ACTIVATORS GLAXO GROUP LTD (GB) 2004-04-28 EP disclosed
EP-1102757-B1 SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS GLAXO GROUP LTD (GB) 2004-04-14 EP disclosed
US-6518290-B1 Compounds that activate or otherwise interact with one or more of the PPARs have been implicated in the regulation of triglyceride and cholesterol levels in animal models SMITHKLINE BEECHAM CORPORATION 2003-02-11 US disclosed
US-6498174-B1 AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME SMITHKLINE BEECHAM CORPORATION 2002-12-24 US disclosed
EP-1244642-A1 SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS HPPAR ALPHA ACTIVATORS GLAXO GROUP LIMITED (GB) 2002-10-02 EP disclosed
EP-1149063-A2 UREIDO-THIOBUTYRIC ACID DERIVATIVES AS PPAR-AGONISTS GLAXO GROUP LIMITED (GB) 2001-10-31 EP disclosed
US-6306854-B1 ARYLTHIOALKYLACIDS AND ALKYL UREAS GLAXOSMITHKLINE 2001-10-23 US disclosed
WO-2001040207-A1 SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS HPPAR ALPHA ACTIVATORS GLAXO GROUP LIMITED (GB) 2001-06-07 WO disclosed
EP-1102757-A1 SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS GLAXO GROUP LIMITED (GB) 2001-05-30 EP disclosed
WO-2000023407-A2 UREIDO-THIOBUTYRIC ACID DERIVATIVES AS PPAR-AGONISTS GLAXO GROUP LIMITED (GB) 2000-04-27 WO disclosed
WO-2000008002-A1 SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS GLAXO GROUP LIMITED (GB) 2000-02-17 WO disclosed